TripdiolideCAS# 38647-10-8 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 38647-10-8 | SDF | Download SDF |
| PubChem ID | 294491 | Appearance | White cryst. |
| Formula | C20H24O7 | M.Wt | 376.40 |
| Type of Compound | Diterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| SMILES | CC(C)C12C(O1)C3C4(O3)C5(CC(C6=C(C5CC7C4(C2O)O7)COC6=O)O)C | ||
| Standard InChIKey | PUJWFVBVNFXCHZ-SQEQANQOSA-N | ||
| Standard InChI | InChI=1S/C20H24O7/c1-7(2)18-13(26-18)14-20(27-14)17(3)5-10(21)12-8(6-24-15(12)22)9(17)4-11-19(20,25-11)16(18)23/h7,9-11,13-14,16,21,23H,4-6H2,1-3H3/t9-,10-,11-,13-,14-,16+,17-,18-,19+,20+/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | Tripdiolide has cytotoxic, and anti-rheumatic activities, it suppresses pro-inflammatory gene expression, may be effective therapy for lupus nephritis. |
| Targets | TNF-α | IL Receptor |
| In vivo | Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F.[Pubmed: 18512813 ]Arthritis Rheum. 2008 Jun;58(6):1774-83.Triptolide and Tripdiolide are thought to be active components of the Chinese antirheumatic herbal remedy Tripterygium wilfordii Hook F, which has been shown to be effective in treating murine lupus nephritis. This study was undertaken to examine the therapeutic effect of triptolide and Tripdiolide on established lupus nephritis in (NZB x NZW)F1 mice.The mean level of anti-dsDNA antibody in mice treated with Tripdiolide was lower than that in the vehicle-treated mice upon completion of the treatment course. Production of tumor necrosis factor, interleukin-6, and monocyte chemoattractant protein 1 by spleen cells was also decreased after diterpenoid therapy.Therapy with triptolide or Tripdiolide significantly ameliorated lupus nephritis in (NZB x NZW)F1 mice, reduced cytokine and chemokine production, and prolonged survival. |
| Structure Identification | Phytochem Anal. 2008 Jul-Aug;19(4):348-52.Determination of tripdiolide in root extracts of Tripterygium wilfordii by solid-phase extraction and reversed-phase high-performance liquid chromatography.[Pubmed: 18288676]Extracts of Tripterygium wilfordii Hook F. have been widely used in China to treat a variety of autoimmune and inflammatory diseases. The diterpenoids triptolide and Tripdiolide are two major active components in the T. wilfordii ethyl acetate extract. An efficient solid-phase extraction and high-performance liquid chromatography (SPE-HPLC) method to measure triptolide content in the extract has been previously reported. However, a suitable means of Tripdiolide quantification is not available because of interfering compounds in the extract that co-elute with Tripdiolide. Therefore, this paper describes a method wherein Tripdiolide content can be measured from a small amount of the extract. Phytochemistry. 2007 Apr;68(8):1172-8.Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii.[Pubmed: 17399748]The extract of Tripterygium wilfordii Hook F. (TwHF), which showed anti-inflammatory and immunosuppressive activities in human clinical trials for rheumatoid arthritis, was subjected to the activity-guided fractionation and spectroscopic characterization of bioactives. Can. J.Chem., 1981, 59(17):2677-83.Cytotoxic diterpenes triptolide, tripdiolide, and cytotoxic triterpenes from tissue cultures of Tripterygium wilfordii[Reference: WebLink]
|
Tripdiolide Dilution Calculator
Tripdiolide Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.6567 mL | 13.2837 mL | 26.5675 mL | 53.135 mL | 66.4187 mL |
| 5 mM | 0.5313 mL | 2.6567 mL | 5.3135 mL | 10.627 mL | 13.2837 mL |
| 10 mM | 0.2657 mL | 1.3284 mL | 2.6567 mL | 5.3135 mL | 6.6419 mL |
| 50 mM | 0.0531 mL | 0.2657 mL | 0.5313 mL | 1.0627 mL | 1.3284 mL |
| 100 mM | 0.0266 mL | 0.1328 mL | 0.2657 mL | 0.5313 mL | 0.6642 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Benzoylpaeoniflorin
Catalog No.:BCN6293
CAS No.:38642-49-8
- Lasiodonin
Catalog No.:BCN7156
CAS No.:38602-52-7
- Chloroprocaine HCl
Catalog No.:BCC5556
CAS No.:3858-89-7
- Prostaglandin F2α
Catalog No.:BCC7889
CAS No.:38562-01-5
- Oxotremorine M
Catalog No.:BCC6920
CAS No.:3854-04-4
- Daphnicyclidin H
Catalog No.:BCN7080
CAS No.:385384-29-2
- Daphnicyclidin F
Catalog No.:BCN6400
CAS No.:385384-26-9
- Daphnicyclidin D
Catalog No.:BCN7081
CAS No.:385384-24-7
- Tarafenacin
Catalog No.:BCC4147
CAS No.:385367-47-5
- Crotafoline
Catalog No.:BCN2075
CAS No.:38494-87-0
- Eucannabinolide
Catalog No.:BCN7221
CAS No.:38458-58-1
- Deacetyleupaserrin
Catalog No.:BCN7228
CAS No.:38456-39-2
- Triptonide
Catalog No.:BCN5924
CAS No.:38647-11-9
- Neodiosmin
Catalog No.:BCN8337
CAS No.:38665-01-9
- Desvenlafaxine Succinate
Catalog No.:BCC5048
CAS No.:386750-22-7
- DAPK Substrate Peptide
Catalog No.:BCC2400
CAS No.:386769-53-5
- Groenlandicine
Catalog No.:BCN8189
CAS No.:38691-95-1
- Preskimmianine
Catalog No.:BCN6667
CAS No.:38695-41-9
- Seneciphylline N-oxide
Catalog No.:BCN5439
CAS No.:38710-26-8
- 3-Epibetulinic acid
Catalog No.:BCN8531
CAS No.:38736-77-5
- Triptolide
Catalog No.:BCN5984
CAS No.:38748-32-2
- Worenine
Catalog No.:BCN2557
CAS No.:38763-29-0
- Swazine
Catalog No.:BCN2143
CAS No.:38763-74-5
- Cucurbitacin D
Catalog No.:BCN2355
CAS No.:3877-86-9
Determination of tripdiolide in root extracts of Tripterygium wilfordii by solid-phase extraction and reversed-phase high-performance liquid chromatography.[Pubmed:18288676]
Phytochem Anal. 2008 Jul-Aug;19(4):348-52.
Extracts of Tripterygium wilfordii Hook F. have been widely used in China to treat a variety of autoimmune and inflammatory diseases. The diterpenoids triptolide and Tripdiolide are two major active components in the T. wilfordii ethyl acetate extract. An efficient solid-phase extraction and high-performance liquid chromatography (SPE-HPLC) method to measure triptolide content in the extract has been previously reported. However, a suitable means of Tripdiolide quantification is not available because of interfering compounds in the extract that co-elute with Tripdiolide. Therefore, this paper describes a method wherein Tripdiolide content can be measured from a small amount of the extract. The extract solution (600 microL) was applied into an aminopropyl SPE tube. Triptolide was eluted with dichloromethane:methanol (1 mL, 49:1 v/v), followed by Tripdiolide elution with dichloromethane:methanol (3 mL, 17:3 v/v). The Tripdiolide eluate was analysed by HPLC using an isocratic solvent system and was quantified by measuring the peak area at 219 nm. The contents of triptolide and Tripdiolide in the extract were determined to be 807.32 +/- 51.94 and 366.13 +/- 17.21 microg/g of extract, respectively. Since Tripdiolide is biologically active and makes up a considerable portion of the extract, for extract quality control and standardisation purposes, it should be measured along with triptolide using the proposed SPE-HPLC method.
Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F.[Pubmed:18512813]
Arthritis Rheum. 2008 Jun;58(6):1774-83.
OBJECTIVE: Triptolide and Tripdiolide are thought to be active components of the Chinese antirheumatic herbal remedy Tripterygium wilfordii Hook F, which has been shown to be effective in treating murine lupus nephritis. This study was undertaken to examine the therapeutic effect of triptolide and Tripdiolide on established lupus nephritis in (NZB x NZW)F1 mice. METHODS: (NZB x NZW)F1 mice were treated with vehicle, triptolide, or Tripdiolide for 15 weeks beginning at the age of 29 weeks (after the development of lupus nephritis). Body weight, proteinuria, and anti-double-stranded DNA (anti-dsDNA) antibodies were monitored, and the kidney and spleen were assessed histologically. Culture supernatants of spleen mononuclear cells were assayed for cytokines. RESULTS: By 28 weeks, most (NZB x NZW)F1 mice had developed lupus nephritis. Vehicle-treated mice exhibited progressive proteinuria, hypoalbuminemia, elevated blood urea nitrogen (BUN) levels, and evidence of severe nephritis. In contrast, proteinuria and BUN levels were significantly reduced in mice treated with either triptolide or Tripdiolide as compared with those treated with vehicle. There was no hypoalbuminemia or apparent evidence of lupus nephritis in mice treated with either of the 2 diterpenoids. At 44 weeks of age, the survival rate in mice treated with vehicle (35.7%) was markedly lower than that in mice treated with either triptolide (87.5%) or Tripdiolide (88.2%). The mean level of anti-dsDNA antibody in mice treated with Tripdiolide was lower than that in the vehicle-treated mice upon completion of the treatment course. Production of tumor necrosis factor, interleukin-6, and monocyte chemoattractant protein 1 by spleen cells was also decreased after diterpenoid therapy. CONCLUSION: Therapy with triptolide or Tripdiolide significantly ameliorated lupus nephritis in (NZB x NZW)F1 mice, reduced cytokine and chemokine production, and prolonged survival.
Anti-inflammatory and immunosuppressive compounds from Tripterygium wilfordii.[Pubmed:17399748]
Phytochemistry. 2007 Apr;68(8):1172-8.
The extract of Tripterygium wilfordii Hook F. (TwHF), which showed anti-inflammatory and immunosuppressive activities in human clinical trials for rheumatoid arthritis, was subjected to the activity-guided fractionation and spectroscopic characterization of bioactives. A tetrahydrofuran lignan, tripterygiol (1), and eight known compounds, all capable of suppressing pro-inflammatory gene expression were identified. Most of the pharmacological activity of the extract can be attributed to triptolide, its most abundant and active component, with some contribution from Tripdiolide.
